What does Société médicale Etienne PASSELECQ do?

Société médicale Etienne PASSELECQ is a specialist medical practice in Baelen. Private Limited, started on 29 June 2006, 2 establishments.

What is the address of Société médicale Etienne PASSELECQ?

The registered office of Société médicale Etienne PASSELECQ is located at Chemin du Giesberg 4, 4837 Baelen.

Is Société médicale Etienne PASSELECQ still active?

Yes. According to the CBE (30 September 2026) Société médicale Etienne PASSELECQ is active, legal situation “Normale toestand”, started on 29 June 2006.

Is Société médicale Etienne PASSELECQ registered on Peppol?

No, Société médicale Etienne PASSELECQ is currently not registered on the Peppol network.

What is the enterprise number of Société médicale Etienne PASSELECQ?

The enterprise number of Société médicale Etienne PASSELECQ is BE0882164520.

When was Société médicale Etienne PASSELECQ founded?

Société médicale Etienne PASSELECQ was founded on 29 June 2006.

Who are the directors of Société médicale Etienne PASSELECQ?

According to the 2025 annual accounts, the directors of Société médicale Etienne PASSELECQ are: Etienne Passelecq.

Is Société médicale Etienne PASSELECQ a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 June 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 2 establishments in the CBE.

How much profit did Société médicale Etienne PASSELECQ make in 2025?

Société médicale Etienne PASSELECQ posted a profit after taxes of € 119,297 in financial year 2025.

What is the revenue of Société médicale Etienne PASSELECQ?

As a small company, Société médicale Etienne PASSELECQ is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 173,538.

Société médicale Etienne PASSELECQ (Private Limited)

Dossier Société médicale Etienne PASSELECQ, printed on 30 September 2026 from databakkes.be/en/0882164520/societe-medicale-etienne-passelecq. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Société médicale Etienne PASSELECQ from Baelen, company number BE0882164520, closed financial year 2025 with a result of € 119,297 after tax. For that financial year Société médicale Etienne PASSELECQ recorded a gross margin of € 173,538 and equity of € 944,867. Compared with financial year 2024, the result moved from € 149,270 to € 119,297. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 15, 2026.

What it is worth Growing

€ 944,867

▲ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 119,297

▼ 20% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 937,055

▼ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 926,267.

People and assets in 2025

Vehicles and equipment

€ 957

▼ 60% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 17,684

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 1,388

▼ 79% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,847

▼ 51% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 182,392 Gross margin 2022: € 182,392 First fiscal year in the series	€ 231,978 Gross margin 2023: € 231,978 ▲ 27% vs 2022 (€ 182,392) Favourable step	€ 195,024 Gross margin 2024: € 195,024 ▼ 16% vs 2023 (€ 231,978) Unfavourable step	€ 173,538 Gross margin 2025: € 173,538 ▼ 11% vs 2024 (€ 195,024) Unfavourable step	▼ 11%
Profit after taxes	€ 115,569 Profit after taxes 2022: € 115,569 First fiscal year in the series	€ 160,812 Profit after taxes 2023: € 160,812 ▲ 39% vs 2022 (€ 115,569) Favourable step	€ 149,270 Profit after taxes 2024: € 149,270 ▼ 7% vs 2023 (€ 160,812) Unfavourable step	€ 119,297 Profit after taxes 2025: € 119,297 ▼ 20% vs 2024 (€ 149,270) Unfavourable step	▼ 20%
Equity	€ 860,488 Equity 2022: € 860,488 First fiscal year in the series	€ 1,021,300 Equity 2023: € 1,021,300 ▲ 19% vs 2022 (€ 860,488) Favourable step	€ 825,570 Equity 2024: € 825,570 ▼ 19% vs 2023 (€ 1,021,300) Unfavourable step	€ 944,867 Equity 2025: € 944,867 ▲ 14% vs 2024 (€ 825,570) Favourable step	▲ 14%
Total debts	€ 36,514 Total debts 2022: € 36,514 First fiscal year in the series	€ 44,922 Total debts 2023: € 44,922 ▲ 23% vs 2022 (€ 36,514) Unfavourable step	€ 362,276 Total debts 2024: € 362,276 ▲ € 317,354 vs 2023 (€ 44,922) Unfavourable step	€ 23,919 Total debts 2025: € 23,919 ▼ 93% vs 2024 (€ 362,276) Favourable step	▼ 93%
Cash	€ 752,117 Cash 2022: € 752,117 First fiscal year in the series	€ 902,834 Cash 2023: € 902,834 ▲ 20% vs 2022 (€ 752,117) Favourable step	€ 1,085,685 Cash 2024: € 1,085,685 ▲ 20% vs 2023 (€ 902,834) Favourable step	€ 937,055 Cash 2025: € 937,055 ▼ 14% vs 2024 (€ 1,085,685) Unfavourable step	▼ 14%
Retained profit	€ 841,888 Retained profit 2022: € 841,888 First fiscal year in the series	€ 1,002,700 Retained profit 2023: € 1,002,700 ▲ 19% vs 2022 (€ 841,888) Favourable step	€ 806,970 Retained profit 2024: € 806,970 ▼ 20% vs 2023 (€ 1,002,700) Unfavourable step	€ 926,267 Retained profit 2025: € 926,267 ▲ 15% vs 2024 (€ 806,970) Favourable step	▲ 15%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 345,000 Dividend 2024: € 345,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 345,000) Unchanged	▼ 100%
Bank debt	€ 30,086 Bank debt 2022: € 30,086 First fiscal year in the series	€ 30,390 Bank debt 2023: € 30,390 ▲ 1% vs 2022 (€ 30,086) Unfavourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 30,390) Favourable step	€ 17,684 Bank debt 2025: € 17,684 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 897,002 Balance sheet total 2022: € 897,002 First fiscal year in the series	€ 1,066,222 Balance sheet total 2023: € 1,066,222 ▲ 19% vs 2022 (€ 897,002) Unchanged	€ 1,187,846 Balance sheet total 2024: € 1,187,846 ▲ 11% vs 2023 (€ 1,066,222) Unchanged	€ 968,787 Balance sheet total 2025: € 968,787 ▼ 18% vs 2024 (€ 1,187,846) Unchanged	▼ 18%

Key figures of Société médicale Etienne PASSELECQ, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Société médicale Etienne PASSELECQ?

What happened at Société médicale Etienne PASSELECQ in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 15, 2026 New annual accounts for financial year 2025: profit of € 119,297 (▼ 20% vs 2024). Source: NBB ↗
Jul 10, 2006 New establishment in Eupen. KBO
Jul 10, 2006 New establishment in Baelen. KBO
Jun 29, 2006 Start of the company according to the CBE. KBO

In short

From € 115,569 profit in 2022 to € 119,297 profit in 2025.

Paid € 237,193 in corporate taxes since 2022.

Best year ever: 2023, with € 160,812 profit.

Paid out € 345,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Société médicale Etienne PASSELECQ? We notify you, reason included.

Follow Société médicale Etienne PASSELECQ

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit